报告题目：What Editors Want: Behind-the-Scenes Perspectives in Manuscript Writing
报告人：Feng Chen, PhD
Director & Executive Publisher ACS Publications
报告题目：Ott1: Controlling hematopoiesis through alternative splicing.
报告人：Glen D. Raffel, MD PhD
Division of Hematology/Oncology
Department of Medicine
University of Massachusetts Medical School
Worcester, Massachusetts, USA
Dr. Feng Chen received her B.S. and M.S. degrees from Peking University. She completed her Ph.D. study at MIT in Dr. Robert Weinberg's Lab at the Whitehead Institute. Dr. Chen conducted postdoctoral research in the laboratory of Frederick Alt at Harvard Medical School. Dr. Chen spent almost a decade at Cell Press-Elsevier, as Editor-in-Chief of Molecular Cell and Executive Editor of the Molecular Biology Portfolio overseeing additional review titles, Trends in Biochemical Sciences and Trends in Genetics. She then joined Harvard University as Director of Research Affairs for the Department of Molecular and Cellular Biology. At the American Chemical Society, Dr. Chen is responsible for the strategic development and editorial management of a multidisciplinary portfolio of ACS Publications, including its flagship title Journal of the American Chemical Society, Chemical Reviews, Accounts of Chemical Research, ACS Nano, Nano Letters, and other distinguished titles in agricultural and food, energy and environmental science, and chemical education. She also plays a leading role in the development of strategic partnerships in China, Asia and beyond. Dr. Chen serves on the Journals Committee of Professional & Scholarly Publishing (PSP), Association of American Publishers, and is a member of the PSP Annual Conference Planning Committee.
Dr. Glen Raffelreceived hisMD, PhD. from Tufts University. He conducted postdoctoral research at Harvard Medical School. He is now an Associate Professor at University of Massachusetts Medical School.
1. Suzuki S, Racine RR, Manalo NA, Cantor SB, Raffel GD. Impairment of fetal hematopoietic stem cellfunction in the absence of Fancd2. Exp Hematol. 2016 Nov 30
2. Xiao N, Laha S, Das SP, Morlock K, Jesneck JL, Raffel GD. Ott1 (Rbm15) regulates thrombopoietinresponse in hematopoietic stem cells through alternative splicing of c-Mpl. Blood. 2015 Feb5;125(6):941-8.
3.Xiao N, Jani K, Morgan K, Okabe R, Cullen DE, Jesneck JL, Raffel GD. Hematopoietic stem cellslacking Ott1 display aspects associated with aging and are unable to maintain quiescence duringproliferative stress. Blood. 2012 May 24;119(21):4898-907.
4. Xiao Nan, Jani K, Yang Y, Raffel GlenD. FLT3ITD Expression Confers the Leukemogenic Properties ofGrowth Factor Independence and Enhanced Self-Renewal to Yolk Sac Progenitors. Blood.2010 November 19; 116(21):1576.
5. Raffel GD, Chu GC, Jesneck JL, Cullen DE, Bronson RT, Bernard OA, Gilliland DG. Ott1 (Rbm15) isessential for placental vascular branching morphogenesis and embryonic development of the heart andspleen. Mol Cell Biol. 2009 Jan;29(2):333-41.
6.Raffel GD, Mercher T, Shigematsu H, Williams IR, Cullen DE, Akashi K, Bernard OA, Gilliland DG.Ott1(Rbm15) has pleiotropic roles in hematopoietic development. Proc Natl Acad Sci U S A. 2007 Apr3;104(14):6001-6.